Active substance
Water for injections
- SFDA 3
- NHS prices 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| WATER FOR INJECTION | 1 ml | Solution for injection/infusion · Intravenous use | 1 Bottle | SAR 6.30 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| WATER FOR INJECTION | 100 ml | Solution for injection/infusion · Intravenous use | 1 Bottle | SAR 4.75 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| WATER FOR INJECTION | 50 ml | Solution for injection/infusion · Intravenous use | 1 Vial | SAR 3.85 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Water for injections 100ml bottles | £52.00 | 20 bottle | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 100ml vials | £88.00 | 25 vial | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 10ml ampoules | £3.92 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 10ml vials | £60.00 | 25 vial | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 20ml ampoules | £21.05 | 20 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 2ml ampoules | £3.30 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Water for injections 5ml ampoules | £3.13 | 10 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.